Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo-Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of MK-5475 in Adults with Pulmonary Arterial Hypertension
Sponsored by Merck Sharp & Dohme Corp.
Active
$235.2K Funding
3 People
External
Related Topics
pulmonary hypertension,
drug efficacy,
clinical trial,
safety
People
Arianna Bedoya
(CD)
College of Medicine - Phoenix
﹒Clinical Research Coordinator III
Elena Young
(CD)
College of Medicine - Phoenix
﹒Research Compliance Manager II
Mason Burchfield
(CD)
College of Medicine - Phoenix
﹒Research Compliance Administrator III
